 It was discovered at the NIH and was licensed and initially developed by Isis Pharmaceuticals, which subsequently licensed it to Novartis.It was licensed by the FDA for CMV in Aug 1998, and was the first antisense drug that was approved.Novartis withdrew the marketing authorization in the EU in 2002 and in the US in 2006.